These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 26537494)

  • 1. Relationship between brain volume loss and cognitive outcomes among patients with multiple sclerosis: a systematic literature review.
    Vollmer T; Huynh L; Kelley C; Galebach P; Signorovitch J; DiBernardo A; Sasane R
    Neurol Sci; 2016 Feb; 37(2):165-79. PubMed ID: 26537494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study.
    Brochet B; Deloire MS; Bonnet M; Salort-Campana E; Ouallet JC; Petry KG; Dousset V
    Mult Scler; 2008 Nov; 14(9):1242-9. PubMed ID: 18653737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test.
    Drake AS; Weinstock-Guttman B; Morrow SA; Hojnacki D; Munschauer FE; Benedict RH
    Mult Scler; 2010 Feb; 16(2):228-37. PubMed ID: 20028710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unemployment in multiple sclerosis (MS): utility of the MS Functional Composite and cognitive testing.
    Strober L; Chiaravalloti N; Moore N; DeLuca J
    Mult Scler; 2014 Jan; 20(1):112-5. PubMed ID: 23635909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
    Sastre-Garriga J; Arévalo MJ; Renom M; Alonso J; González I; Galán I; Montalban X; Rovira A
    J Neurol Sci; 2009 Jul; 282(1-2):120-4. PubMed ID: 19157420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing long-term results of PASAT and SDMT scores in relation to neuropsychological testing in multiple sclerosis.
    Sonder JM; Burggraaff J; Knol DL; Polman CH; Uitdehaag BM
    Mult Scler; 2014 Apr; 20(4):481-8. PubMed ID: 24019305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binocular low-contrast letter acuity and the symbol digit modalities test improve the ability of the Multiple Sclerosis Functional Composite to predict disease in pediatric multiple sclerosis.
    Waldman AT; Chahin S; Lavery AM; Liu G; Banwell BL; Liu GT; Balcer LJ
    Mult Scler Relat Disord; 2016 Nov; 10():73-78. PubMed ID: 27919503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paced visual serial addition test in multiple sclerosis.
    Nagels G; Geentjens L; Kos D; Vleugels L; D'hooghe MB; Van Asch P; Vuylsteke K; De Deyn PP
    Clin Neurol Neurosurg; 2005 Apr; 107(3):218-22. PubMed ID: 15823678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
    López-Góngora M; Querol L; Escartín A
    BMC Neurol; 2015 Mar; 15():40. PubMed ID: 25886168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosis.
    Lazeron RH; Boringa JB; Schouten M; Uitdehaag BM; Bergers E; Lindeboom J; Eikelenboom MI; Scheltens PH; Barkhof F; Polman CH
    Mult Scler; 2005 Oct; 11(5):524-31. PubMed ID: 16193889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
    Papadopoulou A; Müller-Lenke N; Naegelin Y; Kalt G; Bendfeldt K; Kuster P; Stoecklin M; Gass A; Sprenger T; Radue EW; Kappos L; Penner IK
    Mult Scler; 2013 Sep; 19(10):1290-6. PubMed ID: 23459568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognition in multiple sclerosis: Between cognitive reserve and brain volume.
    Fenu G; Lorefice L; Arru M; Sechi V; Loi L; Contu F; Cabras F; Coghe G; Frau J; Fronza M; Sbrescia G; Lai V; Boi M; Mallus S; Murru S; Porcu A; Barracciu MA; Marrosu MG; Cocco E
    J Neurol Sci; 2018 Mar; 386():19-22. PubMed ID: 29406960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients.
    Niccolai C; Portaccio E; Goretti B; Hakiki B; Giannini M; Pastò L; Righini I; Falautano M; Minacapelli E; Martinelli V; Incerti C; Nocentini U; Fenu G; Cocco E; Marrosu MG; Garofalo E; Ambra FI; Maddestra M; Consalvo M; Viterbo RG; Trojano M; Losignore NA; Zimatore GB; Pietrolongo E; Lugaresi A; Pippolo L; Roscio M; Ghezzi A; Castellano D; Stecchi S; Amato MP
    BMC Neurol; 2015 Oct; 15():204. PubMed ID: 26472052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Information-processing speed is the primary deficit underlying the poor performance of multiple sclerosis patients in the Paced Auditory Serial Addition Test (PASAT).
    Forn C; Belenguer A; Parcet-Ibars MA; Avila C
    J Clin Exp Neuropsychol; 2008 Oct; 30(7):789-96. PubMed ID: 18608672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between cognitive changes and neuroradiological changes over time in multiple sclerosis: a systematic review and meta-analysis.
    Simani L; Molaeipour L; Kian S; Leavitt VM
    J Neurol; 2024 Aug; 271(8):5498-5518. PubMed ID: 38890188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients.
    Patti F; De Stefano M; Lavorgna L; Messina S; Chisari CG; Ippolito D; Lanzillo R; Vacchiano V; Realmuto S; Valentino P; Coniglio G; Buccafusca M; Paolicelli D; D'Ambrosio A; Montella P; Brescia Morra V; Savettieri G; Alfano B; Gallo A; Simone I; Viterbo R; Zappia M; Bonavita S; Tedeschi G
    PLoS One; 2015; 10(3):e0120754. PubMed ID: 25816303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The symbol digit modalities test and the paced auditory serial addition test involve more than processing speed.
    Berrigan LI; LeFevre JA; Rees LM; Berard JA; Francis A; Freedman MS; Walker LAS
    Mult Scler Relat Disord; 2022 Dec; 68():104229. PubMed ID: 36279599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive impairment of Japanese multiple sclerosis patients: Follow-up study using BRB-N assessment tool.
    Yoshii F; Takagi S; Nagata E; Hasegawa Y; Kunika N; Maki F; Mochizuki H; Ogino M; Kuroiwa Y
    J Neurol Sci; 2015 Dec; 359(1-2):323-7. PubMed ID: 26671136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symbol Digit Modalities Test: A valid clinical trial endpoint for measuring cognition in multiple sclerosis.
    Strober L; DeLuca J; Benedict RH; Jacobs A; Cohen JA; Chiaravalloti N; Hudson LD; Rudick RA; LaRocca NG;
    Mult Scler; 2019 Nov; 25(13):1781-1790. PubMed ID: 30334474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients.
    Yaldizli Ö; Penner IK; Frontzek K; Naegelin Y; Amann M; Papadopoulou A; Sprenger T; Kuhle J; Calabrese P; Radü EW; Kappos L; Gass A
    Mult Scler; 2014 Mar; 20(3):356-64. PubMed ID: 23959709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.